Scarica l'app Stockscreener
1.61
5.85%
-0.10
Precedente Chiudi:
$1.71
Aprire:
$1.72
Volume 24 ore:
6.09M
Relative Volume:
3.10
Capitalizzazione di mercato:
$145.42M
Reddito:
$70.39M
Utile/perdita netta:
$-43.97M
Rapporto P/E:
-3.1075
EPS:
-0.5181
Flusso di cassa netto:
$-23.85M
1 W Prestazione:
+30.89%
1M Prestazione:
+34.17%
6M Prestazione:
-33.74%
1 anno Prestazione:
-36.36%
Intervallo 1D:
$1.535
$1.94
Intervallo di 1 settimana:
$1.15
$2.13
Portata 52W:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.61 | 145.42M | 70.39M | -43.97M | -23.85M | -0.5181 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Ripresa | Piper Sandler | Overweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-03-01 | Iniziato | Stifel | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-10 | Iniziato | The Benchmark Company | Buy |
| 2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Iniziato | Stephens | Overweight |
| 2017-10-13 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-31 | Iniziato | Jefferies | Buy |
| 2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
Codexis rises after Q4 beat, strong outlook - MSN
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
Codexis Stock Plummets Amid Financial Struggles - StocksToTrade
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Why did CDXS stock jump 7% today? - MSN
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - Sahm
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Sahm
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com UK
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Benzinga
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance By Investing.com - Investing.com Canada
Codexis Shines as Q4 Profit Sparks Investor Enthusiasm - StocksToTrade
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal - Investing.com
Codexis Surpasses Q4 Expectations, Stock Price Volatility Anticipated - timothysykes.com
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Benzinga
Codexis (CDXS) Surges on Strong Q4 2025 Results and Optimistic O - GuruFocus
Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript - Insider Monkey
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha
Codexis, Inc. 2025 Annual Report: Advancements in ECO Synthesis Platform and Pharma Biocatalysis for Therapeutics Manufacturing - Minichart
Codexis: Q4 Earnings Snapshot - theheraldreview.com
Codexis (CDXS) Expects Current Funds to Last Through 2027 - GuruFocus
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Codexis, Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Codexis (CDXS) Surpasses Q4 Expectations for Earnings and Revenue - Bitget
Earnings call transcript: Codexis Surpasses Q4 2025 Expectations with Strong Revenue Growth - Investing.com Canada
CDXS: Strong 2025 revenue and ECO Synthesis progress set the stage for continued growth in 2026 - TradingView
Codexis Q4 Earnings Call Highlights - Yahoo Finance
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Codexis (NASDAQ: CDXS) doubles down on ECO Synthesis RNAi platform amid 2025 loss - Stock Titan
Codexis (CDXS) Exceeds Revenue Expectations, Highlights Technolo - GuruFocus
Codexis Q4 2025 Results: $9.6M Profit, 2026 Revenue Forecast $72M-$76MNews and Statistics - IndexBox
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Codexis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Codexis 2025 10-K: Revenue $70.4M, EPS $(0.50) - TradingView
CDXS: Revenue rose 19% to $70.4M, net loss narrowed, and ECO Synthesis platform advanced - TradingView
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
CODEXIS ($CDXS) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Codexis Q4 Swings to Profit, Revenue Rises - marketscreener.com
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - The Manila Times
Codexis (NASDAQ: CDXS) grows 2025 revenue, trims loss and secures $37.8M Merck deal - Stock Titan
Codexis swings to Q4 profit as Merck deal lifts revenue and funds RNAi push - Stock Titan
Laurence Lytton holds 4.53M shares at Codexis (NASDAQ: CDXS) - Stock Titan
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):